Login to Your Account



Clinic Roundup


Tuesday, February 1, 2011
Sinovac Biotech Ltd., of Beijing, submitted applications to the Chinese SFDA for clinical trials of its pneumococcal polysaccharide vaccines. Preclinical studies showed favorable safety and efficacy profiles in animals.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription